The Weekly Litigation News Digest is now live. Subscribe now
Bendamustine Cyclopolysaccharide Compositions - EP2792369
The patent EP2792369 was granted to Softkemo Pharma on Apr 18, 2018. The application was originally filed on Feb 24, 2010 under application number EP14177306A. The patent is currently recorded with a legal status of "Opposition Rejected".
EP2792369
- Application Number
- EP14177306A
- Filing Date
- Feb 24, 2010
- Status
- Opposition Rejected
- Jul 10, 2020
- Publication Date
- Apr 18, 2018
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (5) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents